1. Signaling Pathways
  2. Protein Tyrosine Kinase/RTK
  3. PDGFR
  4. PDGFR Inhibitors

PDGFR Inhibitors

PDGFR

PDGFRβ

PDGFRα

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

PDGFR Inhibitors
Product Name PDGFR PDGFRβ PDGFRα Purity
Lenvatinib  
PDGFRβ, IC50: 39 nM
PDGFRα, IC50: 51 nM
99.87%
Nintedanib  
PDGFRβ, IC50: 65 nM
PDGFRα, IC50: 59 nM
99.97%
Regorafenib  
PDGFRβ, IC50: 22 nM
  99.96%
Sunitinib  
PDGFRβ, IC50: 2 nM
  99.11%
Ponatinib    
PDGFRα, IC50: 1.1 nM
99.13%
Sunitinib Malate  
PDGFRβ, IC50: 2 nM
  99.47%
Ilorasertib  
PDGFRβ, IC50: 13 nM
PDGFRα, IC50: 11 nM
>98.0%
GZD856  
PDGFRβ, IC50: 136.6 nM
PDGFRα, IC50: 68.6 nM
Axitinib  
PDGFRβ, IC50: 1.6 nM
  99.94%
Crenolanib  
PDGFRβ, Kd: 3.2 nM
PDGFRα, Kd: 2.1 nM
99.67%
SU 5402  
PDGFRβ, IC50: 510 nM
  99.39%
Ripretinib    
PDGFRA
99.46%
Nintedanib esylate  
PDGFRβ, IC50: 65 nM
PDGFRα, IC50: 59 nM
99.93%
Cediranib  
PDGFRβ, IC50: 5 nM
PDGFRα, IC50: 36 nM
99.58%
Dovitinib  
PDGFRβ, IC50: 210 nM
PDGFRα, IC50: 27 nM
97.18%
CP-673451  
PDGFRβ, IC50: 1 nM
PDGFRα, IC50: 10 nM
99.65%
Amuvatinib    
PDGFRαV561D, IC50: 40 nM
PDGFRαD842V, IC50: 81 nM
99.36%
Linifanib  
PDGFRβ, IC50: 66 nM
  99.72%
Pazopanib Hydrochloride  
PDGFRβ, IC50: 84 nM
  99.83%
CHIR-124
PDGFR, IC50: 6.6 nM
    98.07%
Lenvatinib mesylate  
PDGFRβ, IC50: 39 nM
PDGFRα, IC50: 51 nM
99.86%
PP121
PDGFR, IC50: 2 nM
    99.08%
Dovitinib lactate  
PDGFRβ, IC50: 210 nM
PDGFRα, IC50: 27 nM
99.96%
ENMD-2076    
PDGFRα, IC50: 56.4 nM
99.12%
Regorafenib Hydrochloride  
PDGFRβ, IC50: 22 nM
  99.58%
TG 100801  
PDGFRβ, IC50: 13 nM
  98.60%
Ilorasertib hydrochloride  
PDGFRβ, IC50: 13 nM
PDGFRα, IC50: 11 nM
98.91%
SU14813  
PDGFRβ, IC50: 4 nM
  98.90%
Orantinib  
PDGFRβ, Ki: 8 nM
  98.80%
Tandutinib
PDGFR, IC50: 0.2 μM
    99.48%
Regorafenib monohydrate  
PDGFRβ, IC50: 22 nM
  99.96%
Telatinib    
PDGFRα, IC50: 15 nM
98.72%
Toceranib phosphate  
PDGFRβ, Ki: 5 nM
  98.02%
PP58
PDGFR
    99.48%
TAK-593  
PDGFRβ, IC50: 13 nM
PDGFRα, IC50: 4.3 nM
PDGFRαV561D, IC50: 1 nM
99.62%
Toceranib  
PDGFRβ, Ki: 5 nM
  96.25%
JNJ-10198409  
PDGFRβ, IC50: 4.2 nM
PDGFRα, IC50: 45 nM
>99.0%
Cediranib maleate  
PDGFRβ, IC50: 5 nM
PDGFRα, IC50: 36 nM
96.67%
JI-101  
PDGFRβ
  99.95%
ENMD-2076 Tartrate    
PDGFRα, IC50: 56.4 nM
98.59%
Tandutinib hydrochloride
PDGFR, IC50: 0.2 μM
    98.84%
Methylnissolin
PDGFR, IC50: 10 μM
    99.53%
AC710  
PDGFRβ, Kd: 1 nM
PDGFRα, Kd: 1.3 nM
99.89%
SU14813 maleate  
PDGFRβ, IC50: 4 nM
  99.95%
Tyrosine kinase-IN-1    
PDGFRα, IC50: 4 nM
99.47%
PDGFRα kinase inhibitor 1  
PDGFRβ, IC50: 6115 nM
PDGFRα, IC50: 132 nM
99.90%
SU16f
PDGFR2, IC50: 140 nM
PDGFR1, IC50: 2.29 μM
PDGFRβ, IC50: 10 nM
  >99.0%
Tyrphostin AG1433  
PDGFRβ, IC50: 5 μM
  99.20%
NVP-ACC789  
PDGFR-β, IC50: 1.4 μM
  99.94%
AZD2932  
PDGFRβ, IC50: 4 nM
  >98.0%
(Z)-Orantinib  
PDGFRβ, IC50: 0.008 μM
  99.02%
PD-089828  
PDGFR-β, IC50: 1.76 μM
PDGFR-β, Ki: 2.38 μM
 
Tyrphostin AG1296  
PDGFRβ
PDGFRα
Multi-kinase inhibitor 1
PDGFR
   
PD-161570
PDGFR, IC50: 310 nM
PDGFRβ, IC50: 262 nM
 
Hypothemycin  
PDGFRβ, Ki: 900 nM
PDGFRα, Ki: 1.5 μM
SU4312
PDGFR
    98.19%